Date | Total Non-Current Liabilities | Shareholders' Equity | Other Liabilities | Total Liabilities |
---|
CEO | Ms. Caiping Guo |
IPO Date | June 16, 2017 |
Location | China |
Headquarters | No. 3402, Guangqiao Avenue |
Employees | 846 |
Sector | Healthcare |
Industries |
Shenzhen Weiguang Biological Products Co., Ltd. primarily engages in the research, development, production, and sale of blood products in China. The company offers human albumin, intravenous immunoglobulin (pH4), freeze-dried intravenous human immunoglobulin (pH4), human immunoglobulin, hepatitis B human immunoglobulin, rabies patient immunoglobulin, tetanus human immunoglobulin, histamine human immunoglobulin, and human fibrinogen, as well as a total of 9 varieties and 21 specifications. Shenzhen Weiguang Biological Products Co., Ltd. was founded in 1985 and is based in Shenzhen, China.
Past 5 years
USD 1.75
USD 3.10
USD 1.01
USD 1.71
USD 4.11
StockViz Staff
February 2, 2025
Any question? Send us an email